Rethinking prevention The funding crisis reshaping global health has hit HIV prevention particularly hard. At the same time, science is handing us some of the most powerful HIV prevention tools we have ever had – long-acting injectables like lenacapavir and cabotegravir, and a monthly oral pill on the horizon. But science alone does not deliver prevention. That takes systems, policy, funding and a trained healthcare workforce. It takes communities leading in planning, implementation and...